BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2018
View Archived Issues
CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis
Read More
CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers
Read More
Serum netrin-1, a potential early biomarker for impaired fasting glucose and type 2 diabetes
Read More
NOVA2 or DDX6 mutations alter RNA metabolism leading to intellectual disability
Read More
[89]Zr-DFO-dinutuximab as novel radiotracer for selective detection of GD2-positive tumors
Read More
MR-438 peptidomimetic presented as a new radiosensitizing agent in medulloblastoma
Read More
Topline results announced from phase I study of ZYN-001 THC-prodrug patch
Read More
Expanded indication for Sprycel approved in Europe to include treatment of children with CP-CML
Read More
Safety review committee recommends continuation of phase Ib/II SENSITIZE study
Read More
Phase IIb study of LL-37 receives approval in Sweden
Read More
Vertex Pharmaceuticals presents new azoles for demyelinating diseases
Read More
Detection of NDMA in Zhejiang Huahai's valsartan leads to EMA review and product recall
Read More
Boehringer Ingelheim divulges SLC13A5 inhibitors
Read More
EMA validates Clovis' application for Rubraca as maintenance treatment for recurrent ovarian cancer
Read More
Icahn School of Medicine at Mount Sinai discloses PROTAc compounds for cancer
Read More
Nanjing TransThera Biosciences synthesizes protein kinase inhibitors for cancer
Read More
Zydus Cadila and CSIR-IMTECH collaborate to tackle drug-resistant infections
Read More
Medshine Discovery and collaborator patent CCR-2 and CCR-5 antagonists
Read More
Herantis initiates development program for noninvasive CDNF
Read More
Topline results from final analysis of phase II trial of BAN-2401 in Alzheimer's
Read More
MHRA approves Xonvea in U.K. for nausea and vomiting of pregnancy
Read More
Regulus Therapeutics announces corporate restructuring
Read More
Enzyvant partners with Visikol on digital pathology assay to support RVT-802
Read More
Takeda advances acquisition of TiGenix
Read More
Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news
Read More